Retrospective Analysis of the Efficacy of Dapagliflozin in Patients with Type 2 Diabetes in a Primary Clinic in Korea

Retrospective Analysis of the Efficacy of Dapagliflozin in Patients with Type 2 Diabetes in a Primary Clinic in Korea

BackgroundWe aimed to retrospectively analyze the efficacy of 10 mg dapagliflozin (DAPA), which is a sodium-glucose cotransporter-2 inhibitor, in Korean patients with type 2 diabetes who visited a primary diabetes clinic.MethodsIn total, 83 patients with type 2 diabetes, who received treatment with...

Full description

Bibliographic Details
Main Authors: Sang Hyun Park, Young Ju Choi, Eun-Jung Rhee, Kab Bum Huh
Format: Article
Language:English
Published: Academya Publishing Co. 2019-03-01
Series:Endocrinology and Metabolism
Subjects:
Diabetes mellitus, type 2
Dipeptidyl-peptidase IV inhibitors
Dapagliflozin
Primary health care
Retrospective studies
Online Access:https://e-enm.org/Synapse/Data/PDFData/2008ENM/enm-34-70.pdf

Internet

https://e-enm.org/Synapse/Data/PDFData/2008ENM/enm-34-70.pdf

Similar Items